Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Michael Oberst"'
Publikováno v:
Journal for ImmunoTherapy of Cancer. 2(1)
Antibodies targeting T-cell inhibitory pathways, such as CTLA-4 and PD-1/PD-L1, are emerging as an important class of cancer therapeutics, and a next generation of immunomodulatory therapies targeting alternative inhibitory (e.g. TIM-3, LAG-3, B7-H4,